Molbio Diagnostics Limited grew FY26 revenue 41.7% to Rs 1,446 crore on test-kit volumes rising to 17.6 million units, supported by more than 12,500 Truenat devices across 90 countries, but remains exposed to tuberculosis kits at 70.2% of revenue, public-sector procurement and execution of expansion into private, African, Southeast Asian, European and US markets.